Ridgewood Investments LLC Grifols Sa Transaction History

Ridgewood Investments LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$7.14 - $9.29 $397,569 - $517,285	-55,682 Reduced 99.89%	62 $0
Q1 2023 Apr 25, 2023	SELL	$6.65 - $10.69 $21,619 - $34,753	-3,251 Reduced 5.51%	55,744 $410,000
Q4 2022 Jan 19, 2023	SELL	$5.96 - $8.53 $11 - $17	-2 Reduced -0.0%	58,995 $0
Q3 2022 Oct 13, 2022	SELL	$5.95 - $14.3 $41 - $100	-7 Reduced 0.01%	58,997 $363,000
Q2 2022 Jul 19, 2022	BUY	$10.6 - $13.28 $1,696 - $2,124	160 Added 0.27%	59,004 $701,000
Q1 2022 Apr 11, 2022	BUY	$10.37 - $12.73 $17,421 - $21,386	1,680 Added 2.94%	58,844 $687,000
Q4 2021 Jan 18, 2022	BUY	$10.21 - $15.27 $156,049 - $233,386	15,284 Added 36.49%	57,164 $642,000
Q3 2021 Oct 20, 2021	BUY	$14.07 - $17.3 $159,525 - $196,147	11,338 Added 37.12%	41,880 $612,000
Q2 2021 Jul 22, 2021	BUY	$16.62 - $18.94 $102,578 - $116,897	6,172 Added 25.33%	30,542 $530,000
Q1 2021 Apr 27, 2021	BUY	$15.15 - $19.78 $369,205 - $482,038	24,370 New	24,370 $421,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.31B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Ridgewood Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Ridgewood Investments LLC with notifications on news.